Skip to main content
Corey Foster, MD, Radiation Oncology, Oak Lawn, IL, Advocate Christ Medical Center

CoreyChristianFosterMD

Radiation Oncology Oak Lawn, IL

Radiation Oncology

Dr. Foster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Foster's full profile

Already have an account?

Education & Training

  • University of Chicago/University of Illinois College of Medicine at Chicago
    University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2016 - 2020
  • University of Chicago
    University of ChicagoMS, Public Health Sciences, 2018 - 2019
  • Christiana Care Health Services
    Christiana Care Health ServicesInternship, Transitional Year, 2015 - 2016
  • University of Michigan Medical School
    University of Michigan Medical SchoolDoctor of Medicine, Cum Laude, 2011 - 2015
  • DeSales University
    DeSales UniversityBS, Biology, Summa Cum Laude, 2011 - 2015
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 2015

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2021 - 2026
  • TN State Medical License
    TN State Medical License 2020 - 2023
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Alpha Omega Alpha Honor Medical Society 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal Cancer  
    L Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology

Lectures

  • Association of a baseline neutrophil-to-lymphocyte ratio (NLR) with progression-free and overall survival in head and neck cancer patients receiving anti-PD-1 therapy. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Association of immune-related adverse events (irAEs) with improved response, progression-free survival, and overall survival for patients with metastatic head and neck... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Authored Content

  • Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer9/1/2017

Professional Memberships

Hospital Affiliations